Samuel Jones, MD, examines the large reimbursement reductions in cardiac ablations and what the impact might be on access to care in EP labs.

Bullying and other inappropriate workplace behaviors have been linked to an increased risk of errors and worse patient outcomes. 

The drug, which should be available by the end of June, will be marketed under the name Inpefa.

In-hospital mortality and other key outcomes have improved in recent years, but treating these older patients is still associated with certain challenges. 

A new systematic review and meta-analysis of 30 RCTs highlighted numerous benefits associated with vegetarian and vegan diets. Combining a plant-based diet with statin therapy, one researcher noted, could result "in an even larger beneficial effect.”

New research presented at SCAI Scientific Sessions 2023 suggests that marijuana users should understand the early warning signs of PAD, including feelings of pain and coldness in the leg. 

US Heart and Vascular has been busy in 2023, announcing deals with a new investment firm and multiple cardiology practices in the last two months alone.

Signify Research senior analyst Amy Thompson explains the trend of connecting various departments to enterprise imaging systems. She said digital pathology may soon become the third largest user of these systems.

Several hundred AI experts, stakeholders and commentators are alerting the world to the technology’s potential for widespread harm.